Gsk (GSK) Shares Outstanding (2009 - 2026)

Gsk (GSK) has 17 years of Shares Outstanding (Entity) data on file, last reported at $2.2 billion in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Entity) changed 0.03% year-over-year to $2.2 billion; the trailing twelve-month figure through Dec 2025 stood at $2.2 billion (changed 0.03% YoY), and the FY2025 full-year result was $2.2 billion, changed 0.03% from the prior year.
• Shares Outstanding (Entity) was $2.2 billion for Q4 2025 at Gsk, roughly flat from $2.2 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $2.2 billion in Q4 2025 to a low of $2.2 billion in Q4 2021.
• A 5-year average of $2.2 billion and a median of $2.2 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) increased 0.02% in 2023 and rose 0.05% in 2024, its largest moves.
• Gsk's Shares Outstanding (Entity) stood at $2.2 billion in 2021, then climbed by 0.04% to $2.2 billion in 2022, then gained by 0.02% to $2.2 billion in 2023, then gained by 0.05% to $2.2 billion in 2024, then gained by 0.03% to $2.2 billion in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.2 billion in Q4 2025, $2.2 billion in Q4 2024, and $2.2 billion in Q4 2023.